Cargando…
Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice
Influenza is a major public health concern causing millions of hospitalizations every year. The current vaccines need annual updating based on prediction of likely strains in the upcoming season. However, mismatches between vaccines and the actual circulating viruses can occur, reducing vaccine effe...
Autores principales: | Muralidharan, Abenaya, Gravel, Caroline, Harris, Greg, Hashem, Anwar M., Zhang, Wanyue, Safronetz, David, Van Domselaar, Gary, Krammer, Florian, Sauve, Simon, Rosu-Myles, Michael, Wang, Lisheng, Chen, Wangxue, Li, Xuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621047/ https://www.ncbi.nlm.nih.gov/pubmed/35724343 http://dx.doi.org/10.1080/21645515.2022.2083428 |
Ejemplares similares
-
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
por: Gravel, Caroline, et al.
Publicado: (2021) -
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
por: Russell, Marsha S., et al.
Publicado: (2021) -
PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease
por: Muralidharan, Abenaya, et al.
Publicado: (2019) -
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
por: Raman, Sathya N. Thulasi, et al.
Publicado: (2023) -
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
por: Muralidharan, Abenaya, et al.
Publicado: (2018)